Harte Hanks Inc HHS
We take great care to ensure that the data presented and summarized in this overview for HARTE HANKS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HHS
View all-
Blair William & CO Chicago, IL661KShares$3.5 Million0.01% of portfolio
-
Westerly Capital Management, LLC San Francisco, CA625KShares$3.31 Million2.92% of portfolio
-
Kent Lake Pr LLC Anasco, PR365KShares$1.93 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA297KShares$1.58 Million0.0% of portfolio
-
Krilogy Financial LLC148KShares$784,4000.08% of portfolio
-
Credit Suisse Ag Zurich, V8120KShares$636,0000.0% of portfolio
-
Acadian Asset Management LLC Boston, MA114KShares$603,3890.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny97.4KShares$516,1030.0% of portfolio
-
Eidelman Virant Capital70.5KShares$373,6500.59% of portfolio
-
Geode Capital Management, LLC Boston, MA63.5KShares$336,3530.0% of portfolio
Latest Institutional Activity in HHS
Top Purchases
Top Sells
About HHS
Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company provides strategic guidance to help clients to plan and execute omni-channel marketing programs; audience identification, profiling, segmentation and prioritization, predictive modeling, and data strategy services; data hygiene and cleansing services; print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice services; Website and app development, e-commerce enablement, database building and management, platform architecture creation, and marketing automation services; and outsourcing marketing operations solutions. It also offers customer experience management services comprising interact and resolve consumer concerns across hardware and software platforms, healthcare benefit plans, and recalls or a myriad of other customer service issues; CRM and digital transformation solutions to create meaningful customer interactions by connecting content between agent or AI-driven interfaces and web-based self-help tools and community forums; and intelligence-based B2B solutions that understand audiences and their behaviors, and then inspire and drive action to deliver results. In addition, the company provides product, print-on-demand, and mail fulfillment solutions, such as printing on demand, managing product recalls, and distributing literature and promotional products; custom solutions to engage audiences, target customers, support conferences, and appreciate employees; and third-party logistics and freight optimization services. It primarily serves B2B, consumer brand, financial services, retail, and healthcare vertical markets. Harte Hanks, Inc. was founded in 1923 and is headquartered in Chelmsford, Massachusetts.
Insider Transactions at HHS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Dec 05
2024
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
17,225
+0.23%
|
$86,125
$5.84 P/Share
|
Dec 04
2024
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
42,775
+0.53%
|
$213,875
$5.62 P/Share
|
Nov 25
2024
|
David A Garrison Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
850
+6.08%
|
$4,250
$5.8 P/Share
|
Nov 18
2024
|
David A Garrison Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
3,904
+4.63%
|
$23,424
$6.55 P/Share
|
Aug 17
2024
|
John H Griffin Jr Director |
BUY
Other acquisition or disposition
|
Direct |
16,216
+7.58%
|
$113,512
$7.36 P/Share
|
Aug 17
2024
|
John H Griffin Jr Director |
SELL
Other acquisition or disposition
|
Indirect |
16,216
-100.0%
|
$113,512
$7.36 P/Share
|
Aug 17
2024
|
Bradley Louis Radoff Director |
BUY
Other acquisition or disposition
|
Direct |
16,216
+4.66%
|
$113,512
$7.36 P/Share
|
Aug 17
2024
|
Bradley Louis Radoff Director |
SELL
Other acquisition or disposition
|
Indirect |
16,216
-100.0%
|
$113,512
$7.36 P/Share
|
Aug 15
2024
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
23,900
+7.05%
|
$167,300
$7.29 P/Share
|
Aug 14
2024
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
11,993
+3.95%
|
$83,951
$7.08 P/Share
|
Aug 13
2024
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
38,007
+11.98%
|
$266,049
$7.23 P/Share
|
Aug 12
2024
|
David A Garrison Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
4,250
+12.68%
|
$25,500
$6.94 P/Share
|
Aug 12
2024
|
Kirk A Davis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
7,143
+9.81%
|
$42,858
$6.98 P/Share
|
Aug 06
2024
|
Robert T. Wyman General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,624
-6.42%
|
$11,368
$7.92 P/Share
|
Aug 06
2024
|
Robert T. Wyman General Counsel |
BUY
Other acquisition or disposition
|
Direct |
6,667
+20.85%
|
$46,669
$7.92 P/Share
|
Aug 06
2024
|
Robert T. Wyman General Counsel |
SELL
Other acquisition or disposition
|
Indirect |
6,667
-100.0%
|
$46,669
$7.92 P/Share
|
May 31
2024
|
Elizabeth Ross Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,048
+50.0%
|
$84,336
$7.47 P/Share
|
May 29
2024
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,048
+50.0%
|
$84,336
$7.47 P/Share
|
May 29
2024
|
Genevieve Claire Combes Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,048
+50.0%
|
$84,336
$7.47 P/Share
|
May 29
2024
|
John H Griffin Jr Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,048
+50.0%
|
$84,336
$7.47 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 60.7K shares |
---|---|
Other acquisition or disposition | 41.1K shares |
Open market or private purchase | 161K shares |
Other acquisition or disposition | 41.1K shares |
---|---|
Payment of exercise price or tax liability | 2.46K shares |